HAFN Q4 2025 Earnings EPS Misses Estimates as Shares Slide 34 Armata Pharmaceuticals Q1 2026 Earnings Significant EPS Miss but Stock Rises on Pipeline Progress AnaptysBio Inc ANAB Q1 2026 Earnings Significant EPS Miss Amid Clinical Progress ESLA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as ClinicalStage Biotech Continues RD Spending Primoris Services Corporation PRIM Q1 2026 Earnings EPS Misses Estimates Stock Gains on Operational Confidence AirJoule Technologies Corporation AIRJ Q1 2026 Earnings Deep Loss Surprises Market Yet Stock Climbs on Strategic Hopes